Sean Ainsworth, the CEO of Ann Arbor-based RetroSense Therapeutics LLC, will be honored as entrepreneur of the year Thursday night at TechTown Detroit’s annual Toast of the Town awards program. Read more >>
Corbus Pharmaceuticals Holdings, Inc. (CRBP) a clinical stage drug development company targeting rare, chronic and serious inflammatory and fibrotic diseases, announced that Professor Derek Gilroy, Ph.D. presented data on the effects of Resunab in a model of inflammation in healthy volunteers on September 28, 2016. The presentation was made at the 6th European Workshop on Lipid Mediators at Goethe University in Frankfurt am Main, Germany. Read more >>
For 30-year-old Michael Stanek , the chance to see is “overwhelmingly generous.”
A fundraiser for Michael, who has been legally blind from birth, will be held from 1 to 8 p.m. Sunday at the Ashley Fireman’s Park on Ashley Street.
“To think people would do something like that,” Michael said of the event organizers, expressing his gratefulness.
Organizers look to raise $15,000 to allow Michael the chance to buy eSight — a high-tech eyewear device that enhances whatever the user is looking […]
An Independence family is working to raise money so they can get new technology that will help a legally blind boy see.
Corbin Wolfe has been through a lot in his seven years of life. He was a mini preemie, born weighing 1 pound, 14 ounces. He’s had 86 surgeries.
“He’s a miracle,” his mom, Jennie Braden, said.
Braden found eSight while researching online. The company came to Kansas City to do a demo, and the results stunned her. Read more >>
Troy professor Joseph “Joey” Arnold got a phone call three weeks ago and was told that his home had burned to the ground.
His insurance is paying for the house, but it won’t cover something very important to Arnold: a device that helps him see.
Arnold is blind in one eye, and the other eye has a visual acuity of 20/800. The device, eSight, improves his acuity to 20/60.
Students at Troy University, led by the Greek community, set up a fundraiser […]
Corbus Pharmaceuticals (NASDAQ: CRBP) is up 29% at 1:18 p.m. EDT after an analyst at Cantor Fitzgerald initiated coverage of the biotech with a buy rating.
There’s plenty to learn about Corbus Pharmaceuticals. The biotech only has one drug, resunab, but it’s testing the anti-inflammatory drug in multiple indications: cystic fibrosis, systemic sclerosis, dermatomyositis, and lupus. Read more >>
Skyline Medical and GLG Pharma Enter into Partnership to Develop Diagnostic Tests for Skyline’s STREAMWAY SystemZiad
Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the signing of a partnership and exclusive reseller agreement with GLG Pharma, LLC (“GLG”). Read more >>
Leading skin microbiome company AOBiome announced today the launch of its Phase 2B trial using its first-in-class live bacteria to treat acne. Phase 2B marks the advancement from the company’s successful Phase 1B/2A dose-ranging safety study, which resulted in no serious adverse events and no difference in adverse events between treatment and vehicle groups. Read more >>
Professional athletic trainers adopt sam® Sport to accelerate injury recovery and reduce opioid use for pain managementZiad
ZetrOZ Systems, LLC, announced today that the company’s innovative FDA cleared wearable-active ultrasound device – called sam® Sport – is now used widely by professional athletic trainers and physiotherapists in the NFL, NBA, NHL, MLS, MLB and USA Teams. Read more >>
Congratulations to Boston Harbor Angels on Being Named “BUILD Friend of the Year” as Part of the 5-Year Anniversary BUILDFest GalaZiad
BUILD will award Mic Williams and Boston Harbor Angels the “BUILD Friend of the Year Award” as part of their 5-Year Anniversary BUILDFest Gala, which will be held on Wednesday October 19th from 5:30-9:30 pm at the Boston Convention Center.
BUILD and Boston Harbor Angels have partnered and are very happy to be able to bring more resources to help at-risk youth. Read more >>